Clinical Trials

Showing 21 - 40 of 519 trials
Title Investigatorsort icon Disease(s)
A Phase I Study of Single-Dose Radiation Therapy to Treat Spine Metastases that Have Been Irradiated Before
[Protocol 14-054]
Yamada, Yoshiya
  • Spine Tumors
A Pilot Study of Image-Guided Navigation for High-Dose Rate Brachytherapy to Manage Discomfort in Patients with Previously Treated Spine Tumors
[Protocol 12-260]
Yamada, Yoshiya
  • Spine Tumors
A Phase Ib/II Study of LGX818 and Cetuximab with or without BYL719 in Patients with BRAF-Mutant Metastatic Colorectal Cancer
[Protocol 14-019]
Yaeger, Rona
  • Colorectal Cancer
A Phase Ib/II Study of MEK162 plus Panitumumab in Patients with Metastatic Colorectal Cancer
[Protocol 14-044]
Yaeger, Rona
  • Colorectal Cancer
A Phase II Study of Preventive Radiation to the Brain with or without Radiation to Other Parts of the Body for Treating Small Cell Lung Cancer
Relapsed/Refractory
[Protocol 14-194]
Wu, Abraham
  • Lung Cancer, Small Cell
A Phase III Study Evaluating the Addition of Trastuzumab to Standard Therapy for HER2-Positive Esophageal Cancers
[Protocol 12-094]
Wu, Abraham
  • Upper Gastrointestinal
    • Esophageal Cancer
A Phase III Study of Chemotherapy with Either Proton Therapy or Conventional Photon Radiation Therapy to Treat Inoperable Stage II-IIIB Non-Small Cell Lung Cancer
[Protocol 14-189]
Wu, Abraham
  • Lung Cancer, Non-Small Cell
A Study Assessing Lower-Dose Radiation Therapy for High-Risk Neuroblastoma
Newly Diagnosed
[Protocol 14-186]
Wolden, Suzanne
  • Neuroblastoma
A Phase II Study of Whole-Lung IMRT in Children and Adults with Synovial Sarcoma that Spread to the Lungs
[Protocol 14-075]
Wolden, Suzanne
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase I Study of AEB071 in Patients with Metastatic Uveal Melanoma
[Protocol 11-167]
Wolchok, Jedd
  • Melanoma
    • Melanoma of the Eye
A Phase I Study of Mogamulizumab (KW-0761) in Patients with Advanced Solid Tumors
[Protocol 14-135]
Wolchok, Jedd
  • Solid Tumors
A Study of the Biologic Effects of Nivolumab (BMS-936558) in Patients with Inoperable or Metastatic Melanoma
[Protocol 12-231]
Wolchok, Jedd
  • Melanoma
A Phase I Study of IMCgp100 in Patients with Advanced Melanoma
[Protocol 14-152]
Wolchok, Jedd
  • Melanoma
A Phase II Study of CRLX101 plus Bevacizumab versus Standard Therapy in Patients with Advanced Kidney Cancer
[Protocol 14-176]
Voss, Martin
  • Kidney Cancer
A Phase II Study of Axitinib plus Dalantercept or Placebo for Patients with Metastatic Kidney Cancer
[Protocol 12-255]
Voss, Martin
  • Kidney Cancer
A Phase I Study of INK128 (MLN0128) in Patients with Advanced Kidney, Bladder, or Endometrial Cancer
[Protocol 13-118]
Voss, Martin
  • Bladder Cancer
  • Kidney Cancer
A Phase I/II Study of Pazopanib plus MK-3475 (Pembrolizumab) in Patients with Previously Untreated, Inoperable Advanced Kidney Cancer
[Protocol 14-074]
Voss, Martin
  • Kidney Cancer
A Phase I Study of Nivolumab in Combination with Sunitinib, Pazopanib, or Ipilimumab in Patients with Metastatic Renal Cell Carcinoma
[Protocol 12-147]
Voss, Martin
  • Kidney Cancer
A Phase I Study of Debio1347 in Patients with Advanced Cancers Containing FGFR Alterations
[Protocol 13-131]
Voss, Martin
  • Bladder Cancer
  • Breast Cancer
  • Head & Neck Cancer
  • Lung Cancer, Non-Small Cell
    • Other
  • Lung Cancer, Small Cell
  • Solid Tumors
  • Upper Gastrointestinal
    • Gastric Cancer
  • Uterine (Endometrial) Cancer
The Prevention of Delirium and Complications Associated with Surgical Treatments (PODCAST) Clinical Trial
Newly Diagnosed & Relapsed/Refractory
[Protocol 13-240]
Veselis, Robert
  • Psychiatry & Behavioral Sciences
  • Quality of Life